Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PN20 for Thrombocytopenia in Chronic Liver Disease
NCT07446491Phase 2Completed
- Sponsor
- Chongqing Peg-Bio Biopharm Co., Ltd.
- Start
- Jun 2025
- Primary completion
- Oct 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of PJ004 in Thrombocytopenia, sponsored by Chongqing Peg-Bio Biopharm Co., Ltd.. Started Jun 2025; status: completed.
02
Drugs
PJ004
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT07446491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07446491.